Form 4 holding
Director
Tharimmune, Inc.
- Security class
- Options (right to buy)
- Shares / value
- 27,353
- Estimated value
- Report date
- 09 Aug 2024
- Price
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Lynne A. Bui
Insider Reports History
- Reporting-owner location
- Bridgewater, NJ
- Latest reporting-owner signature
-
/s/ Randy Milby as Attorney-In-Fact for Lynne Bui
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Lynne A. Bui
Insider Reports Filed by Lynne A. Bui
4
THAR
Tharimmune, Inc.
- Report period
- 09 Aug 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2024, 17:17
- Role
- Director
- Next action
- Open filing details
4
THAR
Tharimmune, Inc.
- Report period
- 07 Nov 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Nov 2023, 19:55
- Role
- Director
- Next action
- Open filing details
4
THAR
Hillstream BioPharma Inc.
- Report period
- 21 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Mar 2022, 16:15
- Role
- Director
- Next action
- Open filing details
3
THAR
Hillstream BioPharma Inc.
- Report period
- 11 Jan 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 11 Jan 2022, 20:43
- Role
- Director
- Next action
- Open filing details